List of Textbooks of Pharmacovigilance – LINKS – References

by

1. Textbook of Pharmacovigilance: S K Gupta, Jaypee Brothers, Medical Publishers.
2. Practical Drug Safety from A to Z by Barton Colbert, Pierre Byron, Jones and Bartlett
Publishers.
3. Mann’s Pharmacovigilance: Elizabeth B. Andrews, Nicholas, Wiley Publishers.
4. Stephens’ Detection of New Adverse Drug Reactions: John Talbot, Patrick Wale, Wiley
Publishers.
5. An Introduction to Pharmacovigilance: Patrick Waller, Wiley Publishers.
6. Cobert’s Manual of Drug Safety and Pharmacovigilance: Barton Colbert, Jones& Bartlett
Publishers.
7. Textbook of Pharmacoepidemiology edited by Brian L. Strom, Stephen E Kimmel, Sean
Hennessy, and Wiley Publishers.
8. A Textbook of Clinical Pharmacy Practice -Essential Concepts and Skills’. Parthasarathi,
Karin NyfortHansen, Milap C.Nahata
9. National Formulary of India
10. Text Book of Medicine by Yashpal Munjal
11. Text book of Pharmacovigilance: concept and practice by GP Mohanta and PK Manna
12. http://www.whoumc.org/DynPage.aspx?id=105825&mn1=7347&mn2=7259&mn3=7297
12. http://www.ich.org/
13. http://www.cioms.ch/
14. http://cdsco.nic.in/
15. http://www.who.int/vaccine_safety/en/
16. http://www.ipc.gov.in/PvPI/pv_home.html

Gupta SK. Setting up a Pharmacovigilance Center, Text book of Pharmacovigilance. First edition, Jaypee brothers Medical Publishers, 2011; 93-103.

SK Gupta. Post marketing Surveillance, Text book of Pharmacovigilance, First edition, Jaypee Brothers Medical Publishers(P) Ltd., 2011;75.

Srinivasan R, Ramya G. Adverse drug reaction causality assessment. International Journal of Research in Pharmacy and Chemistry. 2011; 1(3): 606-11.

The World Health Organization. Safety of Medicines: A guide for detecting and reporting adverse drug reactions. Geneva :2002 WHO / EDM / QSM / 2002.2.

The National Pharmacovigilance Protocol, Ministry of Health and Family Welfare, Govt of India.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol. 2007; 39: 123. [6] Amit D, Padmanabh V. Rataboli. The adverse drug reaction (ADR) notification drop box: An easy way to report ADRs. Br. J Clin Pharmacol. 2008 November; 66(5): 723-24.

Ravi SP, Subish P, Mishra P, Dubey AK. Teaching pharmacovigilance to medical students and doctors. Indian J Pharmacol. Sept-Oct, 2006;38( 5 ): 316-19.

Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J. Clin Pharm Ther. 2004 Feb; 29(1): 31-35.

Graille V, Lapeyre–Mestre M, Mon Tadric JL. Drug vigilance: An opinion survey which was conducted among the residents of a university hospital. Therapie. 1994 Sep-Oct; 49(5): 451-54.

Ohaju-Obodo, JO, Iribhog be OI. The extent of pharmacovigilance among the resident doctors in the Edo and the Lagos states of Nigeria. Pharmacoepidemiology and Drug Safety. 2010;19: 191-95.

Xu H, Wang Y, Liu N. A hospital based survey on health care profes-sionals in the awareness of pharmacovigilance. Pharmacoepidemioly and Drug Safety, 2009 July;18(7) : 624-30.

Subish P, Izham MM, Mishra P. Evaluation of the knowledge, attitudes and the practices on adverse drug reactions and pharmacovigilance among the health care professionals in a Nepalese hospital: A preliminary study. The Internet Journal of Pharmacology. 2008; 6(1): 1531-2976.

Ramesh M, Parthasarathi G. Adverse drug reaction reporting: the attitudes and the perceptions of the medical practitioners. Asian Journal of Pharmaceutical and Clinical Research. April-June 2009;2 (2):10-14.

 

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: the knowledge, attitude and the practices of the medical students and the prescribers. Natl Med J India. 2002 Jan-Feb; 15(1): 24-6.

Desai, et al. An evaluation of the knowledge, attitude and the practice of adverse drug reaction reporting among the prescribers at a tertiary care hospital. Perspective in Clinical Research. Oct-Dec 2011; 2(4): 129-35.

Gupta P, Udupa A. Adverse drug reaction reporting and pharma-covigilance: knowledge, attitudes and perceptions among the resident doctors. J. Pharm Sci Res 2011; 3:1064-69.

Vora, et al, Knowledge on the adverse drug reactions and the pharmacovigilance activity among the undergraduate medical students of Gujarat. IJPSR. 2012; 3(5): 1511-15

Muraraiah S, et al. A questionnaire study which was done to assess the knowledge, attitude and the practice of pharmacovigilance in a paediatric tertiary care centre. J Chem. Pharm.Res., 2011;3( 6 ): 416-22.

Elkalmi R, et al. Pharmacy students’ knowledge and perceptions about pharmacovigilance in Malaysian public universities. American Journal of Pharmaceutical Education 2011; 75 ( 5 ) Article 96

Risk – Types of RISK – Pharmacovigilance

by

Risk
The probability of harm being caused; the probability (chance, odds) of an occurrence.
Absolute risk
Risk in a population of exposed persons; the probability of an event affecting members of a particular population (e.g. 1 in 1 000). Absolute risk can be measured over time (incidence) or at a given time (prevalence).

Attributable risk
The risk associated with exposure to the monitored medicine(s). This is calculated by subtracting the background risk without the medicine(s) (reference
risk) from the risk measured while taking the medicine(s).
Relative risk
Ratio of the risk in an exposed population (absolute risk) and the risk in an unexposed population (reference risk). Relative risk is the result of a relative comparison between outcome frequency measurements, e.g. incidences.
Reference risk
Risk in a population of unexposed persons; also called baseline risk. Reference risk can be measured over time (incidence) or at a given time (prevalence). The unexposed population refers to a reference population, as closely comparable to the exposed population as possible, apart from the exposure.

 

Serious adverse event or reaction
A serious adverse event or reaction is any untoward medical occurrence that at any dose:
• results in death;
• results in inpatient hospitalization or prolongation of existing hospitalization;
• results in persistent or significant disability or incapacity;
• is life-threatening;
• is a congenital anomaly/birth defect.
To ensure that there is no confusion or misunderstanding about the difference between the terms “serious” and “severe”, the following note of clarification
is provided:
The term “severe” is not synonymous with serious. In the English language, “severe” is used to describe the intensity (severity) of a specific event (as in mild, moderate or severe); the event itself, however, may be of relatively minor medical significance (such as severe headache). Seriousness (not severity) which is based on the outcome of the event on the patient or action
criteria serves as the guide for defining regulatory reporting obligations.

Signal
Reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously. Usually more than a single report is required to generate a signal, depending upon the seriousness of the event and the quality of the information. The publication of a signal usually implies the need for some kind of review or action.

Abbreviations & Definitions of Pharmacovigilance – Interview Help Question & Answers

by

Abbreviations Pharmacovigilance – Interview Help 

  • ADRs adverse reactions to medicines (adverse drug reactions)
  • ATC Anatomic Therapeutic Chemical (Classification for medicines)
  • BCPNN Bayesian Confidence Propagating Neural Network
  • CEM cohort event monitoring
  • CemFlow Cohort Event Monitoring data entry and analytical tool
  • DD (WHO) Drug dictionary
  • ICD 10 WHO International classification of diseases version 10
  • IMAI integrated management of adolescent and adult illness
  • ICSR individual case safety report(s)
  • MedDRA Medical dictionary for drug regulatory activities
  • OI opportunistic infection
  • IMMP (The New Zealand) Intensive Medicines Monitoring Programme
  • PEM prescription event monitoring
  • PvC Pharmacovigilance Centre
  • SOC system organ class
  • SOP standard operating procedure
  • UMC the Uppsala Monitoring Centre
  • VigiBase WHO database of individual case safety (ADR) reports
    (ICSR)
  • VigiFlow spontaneous reporting data entry and analytical tool
  • VigiMine data mining tool available as part of VigiSearch
  • VigiSearch search tool for searching the VigiBase database
  • WHO World Health Organization
  • WHO-ART WHO adverse reactions terminology

Definitions of Pharmacovigilance you must know before attending Interview

Pharmacovigilance
WHO defines Pharmacovigilance as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problems.”
Pharmacovigilance is the process and science of monitoring the safety of medicines and taking action to reduce risks and increase benefits from medicines.

Drug
A drug includes any substance or mixture of substances manufactured, sold or represented for use in:
• the diagnosis, treatment, mitigation or prevention of a disease, disorder or
• abnormal physical state, or its symptoms, in human beings or animals,
• restoring, correcting or modifying organic functions in human beings or animals, or disinfection in premises in which food is manufactured, prepared or kept.

 

Adverse Event (or Adverse Experience)
Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.
An adverse event (AE) can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.

Adverse Drug Reaction (ADR)
In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established:
all noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions.
The phrase “responses to a medicinal product” means that a causal relationship between a medicinal product and an adverse event is at least a reasonable possibility, i.e., the relationship cannot be ruled out.
Regarding marketed medicinal products, a well-accepted definition of an adverse drug reaction in the post-marketing setting is found in WHO Technical Report 498 [1972] and reads as follows:
A response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease or for modification of physiological function.

Causality assessment
The evaluation of the likelihood that a medicine was the causative agent of an observed adverse event. Causality assessment is usually made according to established algorithms.

CemFlow
A sophisticated data management tool created by the UMC data entry and analysis in cohort event monitoring programmes.

Cohort event monitoring
A prospective observational cohort study of adverse events associated with one or more medicines.

Data-mining
At the UMC, this refers to the use of an automated tool, based on Bayesian logic, for the scanning of the WHO database (Vigibase) in the process of detecting adverse reactions associated with medicines:

the Bayesian Confidence Propagating Neural Network (BCPNN). Knowledge-detection is the preferred term for the process.
Individual case safety report (ICSR)
A report that contains information describing a suspected adverse drug reaction related to the administration of one or more medicinal products to an individual patient

Record linkage
Method of assembling information contained in two or more records, e.g. in different sets of medical charts, and in vital records such as birth and death certificates. This makes it possible to relate significant health events that are remote from one another in time and place.

Challenge
Administration of a suspect product by any route.

Dechallenge
The withdrawal of a drug from a patient; the point from which the continuity, reduction or disappearance of adverse effects may be observed. The response to withdrawal may be followed over a period of time.

Dechallenge
Withdrawal of a suspect product from a patient’s therapeutic regimen.
Negative Dechallenge
Continued presence of an adverse experience after withdrawal of the suspect product.
Positive Dechallenge
Partial or complete disappearance of an adverse experience after withdrawal of the suspect product.
Rechallenge
Reintroduction of a suspect product suspected of having caused an adverse experience following a positive dechallenge.
Negative Rechallenge
Failure of the product, when reintroduced, to produce signs or symptoms similar to those observed when the suspect product was previously introduced.
Positive Rechallenge
Reoccurrence of similar signs and symptoms upon reintroduction of the suspect product.

Serious Adverse Event or Adverse Drug Reaction
A serious adverse event (experience) or reaction is any untoward medical occurrence that at any dose:
* results in death,
* is life-threatening,
The term “life-threatening” in the definition of “serious” refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.
* requires inpatient hospitalisation or prolongation of existing hospitalisation,
* results in persistent or significant disability/incapacity,
* is a congenital anomaly/birth defect.

Unlisted / Unexpected Adverse Drug Reaction
An adverse reaction, the nature or severity of which is not consistent with the applicable product information (e.g., Investigator’s Brochure for an unapproved investigational medicinal product and prescribing information / Summary of Product Characteristics (SmPC) for marketed products).

Listed / Expected Adverse Drug Reaction
An ADR whose nature, severity, specificity, and outcome are consistent with the information in the CCSI.

National pharmacovigilance centers
Organizations recognized by governments to represent their country in the WHO Programme (usually the drug regulatory agency). A single, governmentally recognized centre (or integrated system) within a country with the
clinical and scientific expertise to collect, collate, analyse and give advice on all information related to drug safety

Synthon Approach Course Syllabus & Textbooks

by

Synthon Approach – (2 Hr/Wk)
Course Objectives
1. To teach the learner to analyse a target structure in order to design a synthetic scheme.
2. To acquire the expertise toward synthesis by the manipulation of both activation methods and selectivity control.
Course Outcomes
1. Learner will also gain confidence for drawing the schematic retrosynthetic pathway from the course.
2. Learner will be able to analyze the retrosynthetic scheme synthesis planning and route analysis for any given target molecule.

1. Definition of retrosynthesis or disconnection approach, synthon, disconnection, synthetic equivalent, functional group interconversion, functional group addition, functional group removal.
1
2. Guidelines for disconnection
a. Order of events
b. Reversal of polarity
c. Protecting groups

Disconnection of simple alcohols, alkyl halide, ethers, olefins, esters, carboxylic acids,
aldehydes, ketones and amines.
Two group disconnections – 1,2-, 1,3-, 1,4- difunctionalized compounds
Strategies for synthesis of aromatic heterocycles pyrrole, thiophene, furan, pyridine,
pyrimidine

4 Design of retrosynthesis of drugs: Paracetamol, benzocaine, sulfadiazine, ibuprofen,
propranolol, nifedipine, isoniazid, ranitidine, diphenhydramine

Synthon Approach Course Syllabus & Textbooks:

1. Designing organic syntheses: A programmed introduction to the synthon approach, Stuart Warren; Wiley India Pvt Ltd., 2012
2. Designing Organic Syntheses: A Programmed Introduction to the Synthon Approach; Stuart Warren; ISBN: 978-0-471-99612-5,
285 pages, January 1991
3. Organic Synthesis the Disconnection Approach, Stuart Warren, 391pages, ISBN 0 471 10161 3 Paper 1982 by John Wiley and Sons
LTD
4. Synthesis of Drug, A synthon approach by Radhakrishnan P. Iyer & Anant v. prabhu, 1st Edition, (1985) Sevak Publications,
Mumbai.
5. Clayden and Greeves, Organic Chemistry, Oxford University Press (2001)
6. site for solving synthon problems
http://highered.mheducation.com/sites/0073375624/student_view0/chapter22/synthesis_problem_1-2.html

Cosmeticology Course Syllabus & List of Cosmetics Textbooks

by

Cosmeticology

Course Objectives
To provide the learner with knowledge of cosmeticology with respect to the types of formulations, evaluation and regulatory aspects
Course Outcomes
Upon completion of the course, the learner shall be able to:
1. Discuss the various raw materials for cosmetics
2. Understand the toxicological aspects and toxicity testing for cosmetics.
3. Discuss the various cosmetics products w.r.t. raw materials, large scale manufacturing and functional and physicochemical evaluation
4. Know the regulatory guidelines and sensorial assessment for cosmetics

1. General Aspects of Cosmeticology
1.1 Definition of Cosmetics, historical background, classification
Structure of skin, hair, nails, teeth; Regulatory aspects- Schedules to Drug and Cosmetics Rules – M II, S, Q; BIS specifications, Marketing aspects of Cosmetics
2
1.2 Raw materials including oils, fats, waxes, colours, perfumes, antioxidants, preservatives, surfactants, and water, herbal ingredients (Self study and follow up)
1
1.4 Toxicology of cosmetics-irritation and sensitization reactions to cosmetics, sensitivity testing and safety aspects
2
2. Cosmetic formulations: Raw materials, formulation, and functional evaluation of:
a) Skin creams– Cleansing, cold, vanishing, moisturizing, hand and body
products, Face packs, antiacne, antiwrinkle, bleach products
b) Protective preparations- Barrier products; sunscreen, suntan & anti-sunburn
products, insect repellants.
c) Coloured cosmetics-Foundation products, face powders, lipsticks, rouge, eye
cosmetics (Large scale manufacture of lipsticks and face powders, including compact face pwder)
d) Nail specialty products-cuticle softener, nail bleach, nail strengthener, nail whites, nail lacquer
e) Hair care products-Shampoos (including antidandruff & anti lice), hair grooming products [hair setting products, hair sprays, hair tonics, hair conditioners, hair rinses, hair waving & hair straightening products (principles), hair colorants]
f) Depilatories & Shaving products (Wet, Dry & After shave)
g) Oral and personal hygiene preparations-tooth powder, tooth paste, mouth washes, denture cleansers, bath products (soaps, bath salts, bubble baths, shower gels, body washes, anti-perspirants &deodorants
h) Baby toiletries-oils, creams, lotions, shampoos, powders
6. Sensorial evaluation of cosmetics- concept and need, sensory perception, requirements for sensory testing, methods used, interpretation and documentation/representation.

Cosmeticology Text Books:

1. Harry’s Cosmeticology Edited by J.B. Wilkinson and R. J. Moore, Longman Scientific & Technical Publishers
2. Cosmetics Science and Technology, Edited by M.S. Balsam, E. Sagarin, S.D. Gerhon, S.J.Strianse and M.M.Rieger, Volumes 1,2
and 3.Wiley-Interscience, Wiley India Pvt. Ltd.,2008
3. Poucher’s Perfumes, Cosmetics & Soaps, 10th Ed, Editor- Hilda Butler, Klewer Academic Publishers, Netherlands, 2000
4. Cosmetic Technology, Ed. By S.Nanda, A. Nanda and R. Khar, Birla Publications Pvt. Ltd., New Delhi, 2007
5. Handbook of Cosmetic Science and Technology, edited by M. Paye, A.O.Barel, H. I. Maibach, Informa Healthcare USA,Inc. 2007.
6. Encyclopedia of Pharmaceutical Technology, Vol. 6, Eds. James Swarbrick, James C. Boylan, Marcel Dekker Inc., 1992
7. Kemp S.E., Hollowood T, Hort J., “Sensory evaluation-A practical handbook,” John Wiley & Sons, 2009.
8. Sensory Evaluation Techniques, Fourth Edition, Morten C. Meilgaard, B. Thomas Carr, Gail Vance Civille, CRC Press
9. ISO 13299:2016(en) Sensory analysis — Methodology — General guidance for establishing a sensory profile
10. BIS Guidelines for different cosmetic products.
11. Formulation and function of cosmetics by Jellinek Stephan, Wiley Interscience.

Best Pharmacy Books – All Subjects TEXTBOOKS- Chemistry Cology Ceutics Cognosy

by
B. Pharmacy First Year Books List - Subject Notes Books PDF

Organic Chemistry Pharmacy Textbooks Books:

Latest editions of following books to be adopted for the organic chemistry

1. I. L. Finar: Organic chemistry- Volumes 1 and 2, Pearson Education, Ed:5
2. Morrison and Boyd, Organic chemistry, Prentice Hall.
3. Clayden and Greeves, Organic chemistry, Oxford University Press.
4. S. H. Pine et al, Organic chemistry, McGraw-Hill Science/Engineering/Math.
5. D. Lednicer: Steroid chemistry at a glance, Wiley.
6. Heterocyclic Chemistry, Volume I, Volume II, Volume III by R. R. Gupta, M. Kumar, V. Gupta, Publisher: Springer Nature (SIE)
(2009)
7. Fundamental Principles of Polymeric material, Stephen L. Rosen, Second edition, John Wiley and sons, Inc. (1993)

 

Pharmaceutics Pharmacy Textbooks Books:

1. Lachman Leon, Liberman Herbert A., Kaing Joseph L., “Theory and practice of Industrial Pharmacy” 3rd edition,1987, Varghese
Publishing house,Mumbai.
2. Liberman Herbert A., rieger, “Pharmaceutical dosage Forms-Disperse Systems”, vol 1/2/3, 2nd edition,2005, Marcel Dekker Inc.,
New York.
3. Allen, Loyd v V.Jr, “Remingtons- the Science and Practice of Pharmacy, Vol 1 / 2, 22nd edition, Pharmaceutical Press
4. Patrik Sinko Ed.”Martin’s Physical Pharmacy and Pharmaceutical Sciences”, 6th edition, 2010,Lippincott Williams and Wilkins.
5. M.E. Aulton Ed.,”Pharmaceutics-The Science of Dosage Form Design”3rd edition,2007,
Churchill livingstone Elsevier Ltd., UK.
6. E.A. Rawlins Ed.,”Bentley’s Textbook of Pharmaceutics”, 2010, Elsevier Publications.
7. S.J.Carter Ed.,”Tutorial Pharmacy-Cooper & Gunn”, 6th edition,1986, CBS Publishers & distributors, India.
8. Pharmacopeias-IP, BP, USP-latest editions
9. Harry’s Cosmeticology Edited by J. B. Wilkinson and R. J. Moore, Longman Scientific & Technical Publishers
10. Cosmetics Science and Technology, Edited by M. S. Balsam, E. Sagarin, S. D. Gerhon, S. J. Strianse and M. M. Rieger, Volumes
1,2 and 3.Wiley-Interscience, Wiley India Pvt. Ltd.
11. Poucher’s Perfumes, cosmetics & Soaps, Editor- Hilda Butler, Klewer Academic Publishers,Netherlands
12. Cosmetic Technology, Ed. By S. Nanda, A. Nanda and R. Khar, Birla Publications Pvt. Ltd., New Delhi
13. Encyclopedia of Pharmaceutical Technology, Vol. 6, Eds. James Swarbrick, James C. Boylan, Marcel Dekker Inc.
14. BIS Guidelines for different cosmetic products.
15. Formulation and function of cosmetics by Jellinek Stephan, Wiley Interscience.
16. Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins, 2006.

Pharmaceutical Biotechnology Pharmacy Textbooks Books:

1. R. C. Dubey, A textbook of biotechnology
2. B. D. Singh, Biotechnology.
3. S. P. Vyas and Dixit, Pharmaceutical Biotechnology, CBS publisher & distributers.
4. S. S. Kori, Pharmaceutical Biotechnology.
5. H. D. Kumar, Biotechnology, Affiliate East-West press Pvt. Ltd New Delhi.
6. Ananthnarayan, A textbook of microbiology, Orient Longman Pvt. Ltd.
7. W. B. Hugo and A. D. Russell, Pharmaceutical Microbiology, Blackwell Science.
8. David, Nelson, Lehninger – Principle of Biochemistry, W. H. Freeman & Co.
9. Pelezar, Chan & Krieg, Microbiology-Concepts and Applications, International Edn., McGraw Hill, Inc.,
10. Weir Stewart: Immunology, Churchill Livingstone.
11. Chandrakant Kakote, Pharmaceutical Biotechnology.
12.Desmond S.T. Nicholl, An introduction to genetic engineering, Panima Publishing Corporation, New Delhi.
13. Stanbury F. P., Whitakar A., and Hall J.S. Principles of fermentation technology,2nd edition. Aditya books LTD., New Delhi.

Pharmacology Pharmacy Textbooks Books:

1. Goodman & Gilman’s Pharmacological Basis of Therapeutics, McGraw Hill Companies Inc.
2. Satoskar R.S. Bhandarkar S.D. & Rege N. N. Pharmacology & Therapeutics, Popular Prakashan.
3. Rang & Dale Pharmacology, Churchill Livingstone.
4. Lippincott’s Illustrated Reviews: Pharmacology- Lippincott-Raven Howland & Nyeets Publishers NY.
5. Laurence D. R. & Bennett Clinical Pharmacology, Elsevier NY.
6. Kulkarni S. K. Handbook of Experimental Pharmacology, Vallabh Prakashan, New Delhi.
7. Katzung B. G. -Basic and Clinical Pharmacology, Appleton and Lange publications.
8. Ghosh M. N. Fundamentals of Experimental Pharmacology Hilton & Company, Kolkata.

Biochemistry Text books

Books:
1. Meyers, R. A., Molecular Biology and Biotechnology, Wiley-VCH, 2000.
2. Lodish, H. Molecular Cell Biology, 6th Edition, W. H. Freeman and Co., NY, USA.
3. Rose, P. Molecular Biotechnology, Panima, 2000.
4. Brown, T. A., Molecular Biology, Vol. I and II, Academic Press, 2000.
5. B. Lewin, Genes IX, 9th Edition, Jones and Barlett Pub., USA, 2007.
6. Watson J. D. Molecular Biology of the Gene, Benjamin Cummings; 6th Edition, 2007.
7. D,.Nelson and M.Cox, (2005), “Lehninger’s Principles of biochemistry”, 4th ed., Macmillan worth Publishers.

Nutraceuticals and Dietary Supplements -(2 Hr/Wk)

1. Handbook of Nutraceuticals and Functional Foods, Second Edition, Eds Robert E.C. Wildman, CRC Press, Taylor and Francis
2. Nutraceuticals: A Guide for Healthcare Professionals, Brian Lockwood
3. Nutraceuticals in Health and Disease Prevention edited by Klaus Kramer, Peter-Paul Hoppe, Lester Packer, Marcel Decker New
York
4. Nutraceuticals: Efficacy, Safety and Toxicity edited by Ramesh C. Gupta Academic Press, Elsevier Publication
5. Handbook of Nutraceuticals Volume I: Ingredients, Formulations, and Applications edited by Yashwant Vishnupant Pathak, CRC
Press, Taylor and Francis
6. Nutraceuticals edited by Alexandru Grumezescu, Academic Press Elsevier
7. Nutraceuticals, Glycemic Health and Type 2 Diabetes, Eds Vijai K. Pasupuleti, James W. Anderson, Wiley Blackwell Publications
8. Regulation of Functional Foods and Nutraceuticals: A Global Perspective, Ed Clare M. Hasler, Blackwell Publishing
9. Developing New Functional Food and Nutraceutical Products edited by Debasis Bagchi, Sreejayan Nair, Academic Press, Elsevier
Publishing
10. Phytosterols as Functional Food Components and Nutraceuticals, Ed Paresh C. Dutta, Marcel Decker Publishing
11. Phenolics in Food and Nutraceuticals, Fereidoon Shahidi, Marian Naczk, CRC press
12. Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals, Eds Yoshinori Mine, Eunice Li-Chan, Bo Jiang, Wiley
Blackwell
13. Marine Nutraceuticals and Functional Foods, Ed Colin Barrow, Fereidoon Shahidi, CRC press
14. Role of dietary fibres and nutraceuticals in preventing diseases, K. T Agusti and P.Faizal, B S Publication
15. Goldberg, I. Functional Foods. Chapman and Hall, New York.
16. Labuza, T.P. Functional Foods and Dietary Supplements: Safety, Good Manufacturing Practice (GMPs) and Shelf Life Testing in
Essentials of Functional Foods, Eds M.K. Sachmidl and T.P. Labuza, Aspen Press.

Microbial Genetics Text Books

. Peter J. Russell (2006), “Genetics-A molecular approach”, 2nd ed.
2. Benjamin A. Pierce (2008), “Genetics a conceptual approach”, 3rd ed., W. H. Freeman and company.
3. R. H. Tamarin, (2004), “Principles of genetics”, Tata McGraw Hill.
4. D. Nelson and M. Cox, (2005), “Lehninger’s Principles of biochemistry”, 4th ed., Macmillan worth Publishers.
5. M. Madigan, J. Martinko, J. Parkar, (2009), “Brock Biology of microorganisms”, 12th ed., Pearson Education International.
6. Fairbanks and Anderson, (1999), “Genetics”, Wadsworth Publishing Company.
7. Prescott, Harley and Klein, “Microbiology”,. 7th edition Mc Graw Hill international edition.
8. Robert Weaver, “Molecular biology”, , 3rd edn. Mc Graw Hill international edition.
9. Nancy Trun and Janine Trempy, (2004), “Fundamental bacterial genetics”, Blackwell Publishing
10. Snustad, Simmons, “Principles of Genetics”, 3rd edn. John Wiley & sons, Inc.

 Packaging of Pharmaceuticals – (2 Hr/Wk)

‘
1. D. A. Dean, Roy Evans, Ian Hall. Pharmaceutical packaging technology. Tylor and Francis, London.
2. Edward J. Bauer, Pharmaceutical Packaging Handbook. Bausch and Lomb, Rochester, New York, USA.
3. Wilmer A. Jenkins, Kenton R. Osborn. Packaging drugs and pharmaceuticals.
4. Salvatore J. Turco, Sterile dosage forms: their preparation and clinical applications
5. Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins, 2006.
6. Michael E. Aulton, Kevin Tylor (Ed.). Aulton’s Pharmaceutics: The design and Manufacture of Medicine.
7. Gilbert Banker and Christopher Rhodes. Modern Pharmaceutics.
8. Leon Lachman; Lieberman Herbert A.; Kanig, Joseph L. The theory and Practice of Industrial Pharmacy.
9. Hanlon J., Robert J. Kelsey, “Handbook of Package Engineering” 2nd Edition, McGraw-Hill, New. York. 1984
10. Paine A., “Packaging User’s Handbook”, Springer, 1990
11. K. Avis, Liberman and Lachman, Pharmaceutical Dosage Forms: Parenterals, Vol. I, Marcel Dekker, Expanded ad revised edition,
2008.

Pharma Companies Awards List- PHARMA BUSINESS EXCELLENCE AWARDS

by

If you want to know the business EXCELLENCE AWARDS CATEGORIES in pharmaceutical industry you are at the right place. Here we present types of awards your company can receive

Fastest Growing Third Party Manufacturing
Company
Best Distributor Network
Packaging Company with Highest Standards
Innovations in Manufacturing
Innovations in Packaging
Emerging Company in Partnering &
Outsourcing
Innovation in Biologic Drug Development
and Manufacturing
Emerging Company in Packaging
Development
Pharma Marketing Company
Emerging Formulation Company
Innovations in Manufacturing
Innovations in Process and Formulation
Development
Innovations in APIs and Excipients
Innovations in Supply Chain and Logistic
Management
Pharma Company with Largest Distribution
Network
Emerging Pharma Company of the Year
Company of the Year-PCD
Contract Manufacturing – Cosmetic
Formulations
Top Ranked Emerging Pharma Company of
the Year-Ethical Marketing
Pharma Franchise Company in North
Export Driven Pharma Company
Pharma Company for Innovative Marketing
Practices
Emerging Pharma Marketing StrategyCompany of the year
Ophthalmic Drug Portfolio
Dermacare Drug Portfolio
Respiratory Drug Portfolio
Gastroenterology Drug Portfolio
Anti-Diabetic Brand of the Year
Emerging Brand of the year in Oncology
Gynaecology Drug Portfolio
Infectious Disease Portfolio
Drug/Molecule of the Year
Diabetes Drug Portfolio
Cardiac Drug Portfolio
Nutrition Care Portfolio
Paediatric Division
New Launch of the Year
Fastest Growing Company
of the Year in Nephrology
Orthopaedic Drug Portfolio
Innovations in Pharma Technology
Immunology Portfolio
Neurology Drug Portfolio

Top List of Pharmaceutical Manufacturing Companies Types

by

Hello readers. Here we present types of Pharmaceutical Manufacturing Companies. which one you want to choose to work? let us know in comment section below.

 

  • Water Treatment, Waste Water Treatment & Waste Management
    _Packaging Materials & Machineries
  • – Processing Plants & Machineries
  • – Pharma Formulation, API’s Manufacturers
  • – Pharma Machinery and Equipments
  • – Cosmetic & Personal Care
  • – Biotechnology & Clinical Research Organization
  • – Clean Room Equipments & Furniture\
  • – Healthcare products–Ayurvedic & Nutraceutical manufacturers
  • – LabEquipments, Analytical Instruments & Lab Wares
  • – Safety Equipments
  • – IPR Standards & Patent Formulation Bodies
  • – Environment& Pollution Control Bodies
  • – Trade Associations, Trade Promotion Bodies
  • – Track & Trace Solution and Vision inspections Equipments
  • – Track & Trace Solution and Vision inspection Equipments
  • – Bulk Drugs, Intermediates & Formulations
  • – Excipients & Additives
  • – R&D, Quality Control Laboratories
  • – Government Organizations & Industrial Investment Agencies
  • – Software for Pharma Industry & Management

Pharma Related Associations You should know – Pharmaceutical Business Federations India

by
Pharma Related Associations You should know - Pharmaceutical Business Federations India

DDTA-(Delhi Drug Traders Association)
RCDA-(Raipur Chemist & Druggist Association) AICDF-(All
India Chemist & Distributor Federation) RCA-(Rajasthan
Chemist Association)
Sreema Medical Stores
Sikkim Chemists Association
Bengal Chemists’ & Druggists’ Association Ahmedabad
Chemists Association
Federation of Gujarat State Chemists’ & Druggists’
Association
Pharmaceutical Wholesalers Association
Navi Mumbai Retail & Wholesalers Association
Retail & Dispensing Chemist Association
Ratnagiri District Chemist & Druggist Association
Tripura Chemists’ & Druggists’ Association
Anand Chemists’ Association
Gwalior Chemist Association
Jhansi Chemist Association
Jabalpur Chemist & Druggist Association
Bhopal Chemist Association
Indore Chemist Association
Indian Drug Manufacturers’ Association (Tamil Nadu,
Kerala & Puducherry State Board)
The Retail Chemists & Druggists Association, Vijayawada
Kurnool District Druggist Association
Andhra Pradesh Chemists & Druggists Association
Bulk Drug Manufactures Association (India)
All Pharma Chemists & Druggists Association of Telangana
Karnataka State Pharmacy Council
Madras Pharmaceutical Wholesalers Association
The Bangalore District Chemist & Druggists Association
(V. Harikrishnan, President)
Chandigarh Chemist Association
CIPI (Confederation of Indian Pharmaceutical Industry)
Raipur District Chemist & Druggist Association
All India Chemist & Druggist Federation
Lucknow Chemist Association
Pharma Distributor Association
Patna Chemist and Druggists Association
Agra Mahanagar Chemist Association
Indian Pharmacist Association
The Chemist & Druggist Association, Baroda

Pharma Related Associations You should know – Pharmaceutical Business Federations India

please add if you know any other associations in the comment section below

Tamil Nadu Pharmacy Council Complete Registration Process, Documents Required

by

Tamil Nadu Pharmacy Council Complete Registration Process, Documents Required etc.

Under the Section 19 of Pharmacy Act of 1948,the Government Of Madras Constituted  Council of Pharmacy in the state as dated on 15.09.1954.

  The office of Tamil Nadu Pharmacy Council is located in Chennai.

Chennai Pharmacy Registration Fees :

 

 

                         Fee Details                           Amount (Rs.)
 For  D. Pharma                                                          2000.00
 For  B. Pharma                                                          1500.00
 For  Pharm D .                                                        3000.00

 

Documents Required :

 

 

  • For D. Pharm :

 

1) Transfer Certificate

2) SSLC & HSC Mark sheets

3) Course cum Conduct Certificate

4) Diploma in Pharmacy Certificate

5) D.Pharm 1st year and 2nd year Mark sheets

6) Practical Training Contract Form

  • For B. Pharm :

 

1) Transfer Certificate

2) SSLC & HSC Mark sheets

3) Course cum Conduct Certificate

4) B.Pharm Provisional or Degree

5) B.Pharm 1st, 2nd, 3rd & 4th year Mark sheets

  • For Pharm D

 

1) Transfer Certificate

2) SSLC & HSC Mark sheets

3) Course cum Conduct Certificate

4) Pharm D Provisional or Degree

5) Pharm D Mark sheets

6) Internship Certificate issued by the Hospital authorities

 

Step by Step Procedure for Online Registration :

 

  • Visit official website of Tamil Nadu Pharmacy Council Click Here
  • Click  Sign Up
  • Click New Applicant
  • Fill E-mail id and Password
  • Click Sign Up
  • Follow the Activation Link Sent to your E-mail Id
  • Now Log In to tnpc.ac.in with Id and Password
  • Fill Registration Form with Basic Details ( Name, Father’s Name, Birth date)
  • Scan and Upload the Documents in PDF Format as Attachments
  • Scan and Upload Photo and Signature, Photo and Signature must be in .jpg Format with white background*
  • Click Submit

# After submitting the documents, your application will be verified and after verifying

your documents an application link will be sent to you by the council on your mail id.

# After fixing the appointment you should appear at the council office at 10 A.M. on the

given date and pay the fees in cash by the challan at the bank.

Re-Submission

  

   If your application is encountered with improper attachments then you will be informed to RESUBMIT the application through mail with the rectified issue. While resubmitting , you will have to re attach all the documents, photograph and signature.

* Do not scan Photo and Signature with mobile phone